Sleep Disorders Pharmaceutical and Healthcare Pipeline Review 2017

Pune, India, 13th October 2017: WiseGuyReports announced addition of new report, titled “Sleep Disorders Drug Development Pipeline Review, 2017”.

Pune, India - October 13, 2017 /MarketersMedia/ —

Summary
This report provides an overview of the pipeline landscape for sleep disorders. The report provides comprehensive information on the therapeutics under development and key players involved in therapeutic development for Restless Legs Syndrome, Nocturia and Insomnia, and features dormant and discontinued projects.

Restless Legs Syndrome is a neurologic disorder with a core feature of a distressing, irresistible need or urge to move the legs. Risk factors for RLS include low iron levels, kidney failure, Parkinson's disease, diabetes mellitus, rheumatoid arthritis, and pregnancy.

GET SAMPLE REPORT @ https://www.wiseguyreports.com/sample-request/2385279-sleep-disorders-drug-development-pipeline-review-2017

Nocturia, or nocturnal polyuria, describes the excessive urination during night time. Nocturia becomes more common with age and may be symptomatic of the use of diuretic substances, prescription drugs, edema from heart failure, insomnia, pain and prostate or bladder disorders.

Finally, insomnia is a sleep disorder that is characterized by difficulty in falling or staying asleep. Symptoms include difficulty falling asleep at night, waking up during the night, irritability, depression and anxiety.

The size of these pipelines ranges from eight products in restless legs syndrome and nocturia to 31 in insomnia. Across all three of these indications there is a diverse range of molecular targets due to the different pathologies of the indications. The most common targets for restless legs syndrome, nocturia and insomnia therapeutics are D2 dopamine receptor, vasopressin V2 receptor and orexin receptor, respectively.

Scope
- Which companies are the most active within the pipeline for sleep disorder therapeutics?
- Which pharmaceutical approaches are the most prominent at each stage of the pipeline and within each indication?
- To what extent do universities and institutions play a role within this pipeline, compared to pharmaceutical companies?
- What are the most important R&D milestones and data publications to have happened in the field of sleep disorders?

Reasons to buy
- Understand the overall pipeline, with an at-a-glance overview of all products in therapeutic development for each indication
- Assess the products in development in granular detail, with an up-to-date overview of each individual pipeline program in each indication, and a comprehensive picture of recent updates and milestones for each
- Analyze the companies, institutions and universities currently operating in the pipeline, and the products being fielded by each of these
- Understand the composition of the pipeline in terms of molecule type, molecular target, mechanism of action and route of administration

Table of Content: Key Points

1 Table of Contents 4
1.1 List of Tables 5
1.2 List of Figures 6
2 Introduction 7
2.1 Sleep Disorders Report Coverage 7
2.2 Restless Legs Syndrome - Overview 7
2.3 Nocturia - Overview 7
2.4 Insomnia - Overview 7
3 Therapeutics Development 8
3.1 Restless Legs Syndrome 8
3.2 Nocturia 11
3.3 Insomnia 14
4 Therapeutics Assessment 21
4.1 Restless Legs Syndrome 21
4.2 Nocturia 27
4.3 Insomnia 33
5 Companies Involved in Therapeutics Development 39
5.1 Restless Legs Syndrome 39
5.2 Nocturia 42
5.3 Insomnia 44
6 Dormant Projects 53
6.1 Restless Legs Syndrome 53
6.2 Nocturia 53
6.3 Insomnia 54
7 Discontinued Products 56
7.1 Restless Legs Syndrome 56
7.2 Insomnia 56
8 Product Development Milestones 58
8.1 Restless Legs Syndrome 58
8.2 Nocturia 63
…Continued

Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts

Contact Info:
Name: NORAH TRENT
Email: Send Email
Organization: WISEGUY RESEARCH CONSULTANTS PVT LTD
Address: Office No. 528, Amanora Chambers
Phone: +91 841 198 5042

Source URL: https://marketersmedia.com/sleep-disorders-pharmaceutical-and-healthcare-pipeline-review-2017/250082

For more information, please visit http://www.wiseguyreports.com

Source: MarketersMedia

Release ID: 250082

Latest News

The Latest: Trump warns Turkey over detained pastor

Aug 17, 2018

ANKARA, Turkey — The Latest on Turkey's currency crisis and diplomatic dispute with the United States (all times local): 6:30 p.m. U.S. President Donald Trump is condemning the detention of an American pastor in Turkey and warned that "we are not going to take it sitting down." Trump, before leaving the White House on Friday, denounced Turkey as a "problem for a long time" and said it made up a "phony" spying charge against Andrew Brunson. Brunson was charged with terror offenses by a Turkish court and has been held since October 2016. Trump said Turkey has "not acted like...

Turkish lira resumes fall after Trump sanctions threat

Aug 17, 2018

ISTANBUL — The Turkish currency fell again on Friday, breaking a three-day quiet spell in the country currency crisis, after the United States threatened to impose new sanctions on the NATO country. The lira dropped about 5 percent, to about 6.11 per dollar, after U.S. President Donald Trump posted a tweet warning the country of more punitive measures over the continued detention in Turkey of American pastor Andrew Brunson, an evangelical pastor who faces 35 years in prison on charges of espionage and terror-related charges. Turkey's trade minister, Ruhsar Pekcan, said her government would respond to any new trade duties....

Turkish finance chief tries to reassure investors on crisis

Aug 17, 2018

ANKARA, Turkey — Turkey's finance chief tried to reassure thousands of international investors on a conference call Thursday, in which he pledged to fix the economic troubles that have seen the country spiral into a currency crisis. The national currency recovered somewhat from record lows hit earlier this week, a day after Qatar pledged $15 billion in investments to help Turkey's economy. The lira strengthened some 4 percent against the dollar, to around 5.75 per dollar. Treasury and Finance Minister Berat Albayrak was quoted by private media NTV as saying the economy would emerge stronger from the turmoil. Albayrak said...

The Latest: Trump tweets support for pastor jailed in Turkey

Aug 17, 2018

ANKARA, Turkey — The latest on Turkey's currency crisis (all times local): 2:55 a.m. President Donald Trump is calling on jailed pastor Andrew Brunson to serve as a "great patriot hostage" while he's being held in Turkey. Tweeting on Thursday, Trump says: "Turkey has taken advantage of the United States for many years" and is criticizing the country for "holding our wonderful Christian Pastor." Trump adds, "We will pay nothing for the release of an innocent man, but we are cutting back on Turkey!" Brunson has been detained on espionage and terrorism-related charges. The Trump administration has said Turkey could...

Challenged by US and market crisis, Turkey turns to Europe

Aug 17, 2018

ISTANBUL — Beset by a shaky currency and tension with the United States, Turkey is reaching out to Europe to shore up relations with major trading partners despite years of testy rhetoric and a stalled bid for EU membership. The engagement by Turkish President Recep Tayyip Erdogan, who has harshly criticized Germany and other European nations in the past, is part of a diplomatic campaign to capitalize on international unease over U.S. President Donald Trump and American tariff disputes around the world. Also this week, Qatar pledged $15 billion in investments in Turkey and Russia's foreign minister talked about using...

About Us

Get a quick look at what’s happening in the world today with in-depth analysis on international news, politics, business and technology, only in Central News Today.

Contact us: sales[at]centralnewstoday.com

Subscribe Now!